STOCK TITAN

ThermoGenesis Holdings to Announce Financial Results for the Fourth Quarter Ended December 31, 2020 and Provide a Corporate Strategic Update

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

ThermoGenesis Holdings, Inc. (Nasdaq: THMO) will announce its fourth-quarter financial results for the period ending December 31, 2020, on March 17, 2021, after market close. The company will also provide a corporate strategic update during a conference call and webcast scheduled for 1:30 p.m. PT/4:30 p.m. ET. Participants can join the call by dialing specific numbers for domestic and international listeners. A replay of the webcast will be accessible on the company’s website for three months.

Positive
  • None.
Negative
  • None.

RANCHO CORDOVA, Calif., March 10, 2021 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the fourth quarter ended December 31, 2020 and provide a corporate strategic update on Wednesday, March 17, 2021, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

To participate in the conference call, please dial 1-844-889-4331 (domestic), 1-412-380-7406 (international) or 1-866-605-3852 (Canada). To access a live webcast of the call, please visit: https://thermogenesis.com/investors/news-and-events/events-webcasts.

A webcast replay will be available on ThermoGenesis' website for three months by visiting the Investor page of the Company's website at www.thermogenesis.com.

About ThermoGenesis Holdings, Inc.

ThermoGenesis Holdings, Inc. develops, commercializes, and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, functionally-closed CAR-TXpress™ platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. For more information about ThermoGenesis, please visit: www.thermogenesis.com.

Company Contact:
Wendy Samford
916-858-5191
ir@ThermoGenesis.com

Investor Contact:
Paula Schwartz, Rx Communications
917-322-2216
pschwartz@rxir.com

 

Cision View original content:http://www.prnewswire.com/news-releases/thermogenesis-holdings-to-announce-financial-results-for-the-fourth-quarter-ended-december-31-2020-and-provide-a-corporate-strategic-update-301244310.html

SOURCE ThermoGenesis Holdings, Inc.

FAQ

When will ThermoGenesis announce its financial results for Q4 2020?

ThermoGenesis will announce its financial results for the fourth quarter ended December 31, 2020, on March 17, 2021.

What time is the conference call for ThermoGenesis' financial results?

The conference call is scheduled for 1:30 p.m. PT / 4:30 p.m. ET on March 17, 2021.

How can I access the ThermoGenesis webcast?

The live webcast can be accessed via ThermoGenesis' investor page on their website.

What is the stock symbol for ThermoGenesis?

The stock symbol for ThermoGenesis is THMO.

ThermoGenesis Holdings, Inc.

NASDAQ:THMO

THMO Rankings

THMO Latest News

THMO Stock Data

5.37M
11.41M
4.11%
2.27%
1.76%
Medical Devices
Laboratory Apparatus & Furniture
Link
United States of America
RANCHO CORDOVA